Ligand validation:8DXK

BYZ: 4-bromo-1H-pyrazole

BYZ is a Ligand Of Interest in 8DXK designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
8DXK_BYZ_B_508	27%	66%	0.256	0.905	0.67	0.63	-	-	2	0	100%	0.255
8DXK_BYZ_B_510	5%	66%	0.335	0.746	0.67	0.64	-	-	4	0	100%	1
8DXK_BYZ_A_611	3%	59%	0.312	0.626	0.9	0.69	-	-	2	0	100%	1
8DXK_BYZ_A_613	1%	66%	0.31	0.489	0.68	0.64	-	-	0	0	100%	1
8DXK_BYZ_B_509	1%	67%	0.544	0.612	0.67	0.62	-	-	2	0	100%	1
8DXK_BYZ_A_610	0%	66%	0.469	0.503	0.68	0.62	-	-	1	0	100%	1
8DXK_BYZ_A_612	0%	67%	0.515	0.392	0.66	0.61	-	-	3	0	100%	1
8DXK_BYZ_A_609	0%	67%	0.642	0.205	0.66	0.62	-	-	2	0	100%	0.45
5CYQ_BYZ_A_608	63%	6%	0.154	0.951	2.21	2.91	1	3	0	0	100%	1
4KAH_BYZ_A_404	62%	5%	0.139	0.932	2.35	3.11	2	3	2	0	100%	1
5CXR_BYZ_A_305	59%	49%	0.155	0.938	1.51	0.48	1	-	0	0	100%	1
6Q3C_BYZ_A_301	25%	17%	0.177	0.814	1.3	2.29	1	2	0	0	100%	0.5
7Z9W_BYZ_AAA_203	18%	48%	0.32	0.913	1.15	0.85	1	-	5	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.